Fig. 3
From: Effects of peptides derived from active sites of visfatin on wound healing
Wound healing effects of Vis-1 in full-thickness wound models. Representative images of wounds healing on day 0, 2, 4, 6, 8, and 10 after injury (A). Quantification of the wound closure rate in different groups (Control, 20µM hEGF, 1µM Vis-1, and 20µM Vis-1) at various time points (Day 2, 4, 6, 8 and 10) (B). Data represent the average of three independent experiments and are expressed as a mean ± SEM.*p < 0.05 (vs. control). hEGF human epidermal growth factor, Vis-1 visfatin-derived peptide-1.
